Search results
Kids and Anti-Obesity Meds: Real-World Challenges
Medscape· 17 hours agoThe ability to provide adolescents with highly effective anti-obesity medications that now carry approvals from the US Food and Drug Administration (FDA)...
Alabama is nation’s 7th worst state, according to US News report
Birmingham News· 18 minutes agoLaunched in 2017 as the first comprehensive study of the 50 states based on a wide set of criteria,...
Ozempic Face — and Now Ozempic Breast and Butt? What's Really Going on with These Side Effects?
People via Yahoo News· 2 days agoNever miss a story — sign up for PEOPLE's free daily newsletter to stay up-to-date on the best of...
Is Eli Lilly Stock A Buy Or A Sell As FDA Plans Meeting To Discuss Alzheimer's Drug?
Investor's Business Daily· 1 day agoAlzheimer's Treatment News Hits LLY Stock Eli Lilly is angling for FDA approval of donanemab, a...
Colorectal cancer cases have tripled in teens—and jumped by 500% in kids. What you need to know
Fortune via Yahoo Finance· 2 hours agoWhy is this happening? “We really don’t know,” Marshall says. In general, known genetic risk factors...
Local obesity drug developer lands deal worth up to $600M with Novo Nordisk - Boston Business...
The Business Journals· 1 day agoAn obesity-focused startup that spun out of Cambridge’s Flagship Pioneering last year has forged a...
Weight loss: New endoscopic procedure could help reduce hunger hormone
Medical News Today· 13 hours agoResearchers say a new procedure that burns stomach lining may help decrease production of hunger hormone ghrelin. Ghrelin levels are typically higher in people with obesity
If at First Tirzepatide Doesn't Succeed, Keep Trying
Medscape· 17 hours agoWhen using tirzepatide (Zepbound, Eli Lilly) to treat obesity, patience may pay off. New post hoc data from Lilly's SURMOUNT-1 trial of people with...
Breaking Down Japan's Food Culture
Time via AOL· 1 day agoIt sounded, at first glance, like great news for Novo Nordisk, the company that makes Ozempic and Wegovy. But industry outlet the Pharma Letter explained...
Continuous Glucose Monitors Gain Favor in Obesity
Medscape· 4 days agoWith continuous glucose monitors (CGMs) becoming vital tools for managing diabetes, the technology, soon to become available over the counter, is gaining...
